Biopharma pushes beyond GLP-1s, weight loss at ObesityWeek 2026
ObesityWeek 2026, which kicks off on Saturday, will spotlight presentations on the ascendant amylin pathway, as well as therapies looking to improve the quality of weight loss and patients’ persistence on treatment.
comments(0)
5-min edit window · permanent after that